James Choi, MD
Urology Physician in Flemington, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,367 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
James Choi, MD reported a CMS MIPS final score of 90.1/100 - above the 83.1 national average - and filed 3,770 Medicare Part D claims in 2023.
- 90.1/100
- MIPS score · +7 vs avg
- 4K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
James Choi, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
90 Top 40% higher than 60% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where James Choi, MD sits
This provider among urology physician peers
Across the 4,623 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, James Choi, MD writes more Part D claims than 94% of them and scores higher on MIPS quality than 60% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one urology physician peer from a representative sample of 60; the gold marker is James Choi, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
James Choi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James Choi, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Urology Physician compares to other specialties among New Jersey providers
Urology Physician ranks #64 among New Jersey's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Urology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
James Choi, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 90.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Urology Physician) - 90.1/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Cost dim CMS Cost category
- Specialty volume Urology Physician US NPIs
90.1/100 MIPS final score - 7.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Urology Physician. Cost dim: 50.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
James Choi, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 5 WALTER FORAN BLVD, Flemington, NJ, 08822, with a listed phone of (908) 751-5939. NPI 1255321519 was issued on 10/26/2005.
Medicare Part D records for calendar year 2023 show 3,770 prescription claims written by this provider, covering 843 Medicare beneficiaries and totaling roughly $248K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.1/100 for the 2023 performance year, compared with the national average of 83.1.
Urology Physician is a mid-sized specialty nationwide, with 13,367 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1255321519 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/26/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm James Choi, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1255321519 is the unique 10-digit identifier CMS uses to link Choi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,340
- Total Day Supply
- 264,118
- Generic Drug Cost
- $86K
- Antibiotic Claims
- 617
Patient Demographics
- Average Patient Age
- 76.2 years
- Avg HCC Risk Score
- 1.26
- Gender Split
- 17% female / 83% male
- Age Distribution
- <65: 20, 65-74: 334, 75-84: 365, 85+: 124
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What James Choi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Finasteride
Finasteride
1,315 claims
- Tamsulosin Hcl
Tamsulosin Hcl
1,035 claims
- Nitrofurantoin Mon… 267
Nitrofurantoin Mono-Macro
267 claims
- Ciprofloxacin Hcl 187
Ciprofloxacin Hcl
187 claims
- Dutasteride 180
Dutasteride
180 claims
- Myrbetriq 127
Myrbetriq
127 claims
- Oxybutynin Chlorid… 103
Oxybutynin Chloride Er
103 claims
- Sulfamethoxazole-T… 76
Sulfamethoxazole-Trimethoprim
76 claims
| Drug | Claims |
|---|---|
| Finasteride | 1,315 |
| Tamsulosin Hcl | 1,035 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 267 |
| Ciprofloxacin Hcl | 187 |
| Dutasteride | 180 |
| Myrbetriq Mirabegron | 127 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 103 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 76 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 68 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 66 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How James Choi, MD fits within the Urology Physician landscape nationally.
James Choi, MD's 3,770 claims are above the specialty average of 1,280.
Nearby Urology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Choi.
Compare Urology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Urology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is James Choi, MD's specialty? ▼
How much does James Choi, MD prescribe under Medicare Part D? ▼
What is James Choi, MD's Medicare quality score? ▼
Where is James Choi, MD located? ▼
What is James Choi, MD's NPI number? ▼
How many Urology Physician providers are there in the US? ▼
What drugs does James Choi, MD prescribe most often? ▼
Does James Choi, MD accept Medicare? ▼
How can I verify James Choi, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.